Enhanced efficacy of simultaneous PD-1 and PD-L1 immune checkpoint blockade in high grade serous ovarian cancer

Immune therapies have had limited efficacy in high grade serous ovarian cancer (HGSC), as the cellular targets and mechanism(s) of action of these agents in HGSC are unknown. Here we performed immune functional and single cell RNA-seq transcriptional profiling on novel HGSC organoid/immune cell co-c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res
Main Authors: Wan, Changxin, Keany, Matthew P., Dong, Han, Al-Alem, Linah F., Pandya, Unnati M., Lazo, Suzan, Boehnke, Karsten, Lynch, Katherine N., Xu, Rui, Zarrella, Dominique T., Gu, Shengqing, Cejas, Paloma, Lim, Klothilda, Long, Henry W., Elias, Kevin M., Horowitz, Neil S., Feltmate, Colleen M., Muto, Michael G., Worley, Michael J., Berkowitz, Ross S., Matulonis, Ursula A., Nucci, Marisa R., Crum, Christopher P., Rueda, Bo R., Brown, Myles, Liu, Xiaole Shirley, Hill, Sarah J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7878408/
https://ncbi.nlm.nih.gov/pubmed/33158814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-20-1674
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados